文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

[Treatment status and progress of laryngopharyngeal reflux disease].

作者信息

Yang Junjie, Bianba Duojie, Xie Shenwei, Ji Di, Zhang Yi, Deng Anchun

机构信息

Department of Otolaryngology Head and Neck Surgery,the Second Affiliated Hospital of Army Medical University,Chongqing,400037,China.

Department of Otolaryngology Head and Neck Surgery,953 Hospital of PLA Army.

出版信息

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2025 May;39(5):491-495. doi: 10.13201/j.issn.2096-7993.2025.05.019.


DOI:10.13201/j.issn.2096-7993.2025.05.019
PMID:40263664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12408141/
Abstract

Laryngopharyngeal reflux disease refers to a series of symptoms and signs caused by gastroduodenal contents regurgitate into the upper respiratory, digestive tract above the upper esophageal sphincter. In recent years, with the deepening of the pathogenesis, the treatment plan of this disease is constantly updated and optimized, but there is still no gold standard for treatment. This paper summarizes the treatment of pharyngeal reflux disease and proposes that based on proton pump inhibitors, potassium competitive acid blockers and alginate can be used as alternative therapy for proton pump inhibitors. Meanwhile, the external upper esophageal sphincter pressure device has sufficient potential value to be concerned. Lifestyle change and dietary structure adjustment should be used as the basic treatment throughout. To provide directions for further treatment of the disease.

摘要

相似文献

[1]
[Treatment status and progress of laryngopharyngeal reflux disease].

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2025-5

[2]
Pharmacological treatment of children with gastro-oesophageal reflux.

Cochrane Database Syst Rev. 2014-11-24

[3]
Prescription of Controlled Substances: Benefits and Risks

2025-1

[4]
Safety and efficacy of proton pump inhibitors in preterm infants with gastroesophageal reflux disease.

Cochrane Database Syst Rev. 2025-3-11

[5]
Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: Joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), and General Medicine (SIMG).

Dig Liver Dis. 2025-5-30

[6]
Gastroesophageal reflux in pregnancy: a systematic review on the benefit of raft forming agents.

Minerva Ginecol. 2013-10

[7]
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].

Zhonghua Jie He He Hu Xi Za Zhi. 2025-3-12

[8]
Pharmacological treatment of gastro-oesophageal reflux in children.

Cochrane Database Syst Rev. 2023-8-22

[9]
Acid Assault: Unmasking the Toll of Laryngopharyngeal Reflux Disease on Vocal Health - A Literature Review.

Indian J Otolaryngol Head Neck Surg. 2025-2

[10]
ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.

Arq Gastroenterol. 2017-12

本文引用的文献

[1]
Omeprazole taken once every other day can effectively prevent aspirin-induced gastrointestinal mucosal damage in rats.

BMC Gastroenterol. 2024-5-29

[2]
Development of Gastric Polyps: 15 Years of Proton Pump Inhibitor Therapy.

Cureus. 2024-5-21

[3]
Laryngopharyngeal reflux disease: Updated examination of mechanisms, pathophysiology, treatment, and association with gastroesophageal reflux disease.

World J Gastroenterol. 2024-4-28

[4]
ChatGPT-4 accuracy for patient education in laryngopharyngeal reflux.

Eur Arch Otorhinolaryngol. 2024-5

[5]
Causal relationship between gut microbiota and risk of gastroesophageal reflux disease: a genetic correlation and bidirectional Mendelian randomization study.

Front Immunol. 2024

[6]
Review article: Diagnosis and management of laryngopharyngeal reflux.

Aliment Pharmacol Ther. 2024-3

[7]
Refractory Gastroesophageal Reflux Disease: Diagnosis and Management.

J Neurogastroenterol Motil. 2024-1-30

[8]
Efficacy and Safety of Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors as Helicobacter pylori Eradication Therapy: A Meta-Analysis of Randomized Clinical Trials.

Cureus. 2023-11-7

[9]
Algae Food Products as a Healthcare Solution.

Mar Drugs. 2023-11-5

[10]
Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?

BMC Gastroenterol. 2023-9-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索